This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources    Join ASCLS June. 7, 2011
ASCLS eNewsBytes
June. 7, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources


Exemestane prevents 65 percent of invasive breast cancers in postmenopausal women
Internal Medicine News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A daily dose of the aromatase inhibitor exemestane reduced invasive breast cancers by 65 percent in a placebo-controlled chemoprevention trial that enrolled 4,560 postmenopausal women considered at increased risk of the disease. Pre-invasive breast cancers and precancerous lesions also were much less common at a median follow-up of three years in the study, which is expected to reopen a stalled conversation between women and their physicians regarding the risks and benefits of chemoprevention. More
Related story:
Drug that treats breast cancer found to prevent it, too (CNN)




BioConference Live Summer: Clinical Diagnostics
ASCLS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The BioConference Live Summer: Clinical Diagnostics is scheduled for June 15-16. This conference is completely online and will offer topics such as: Infectious disease, oncology, cardiology, diabetes, molecular diagnostics, point of care, laboratory testing, and more.

Sessions are P.A.C.E. approved. BioConference Live is partnered with ASCLS. BioConference Live is the world's largest series of online-only conferences focused on the life science and clinical diagnostics community.

Register and attend for free at http://www.bioconferencelive.com.


DNA sequence yields clues to Germany's 'super toxic' E. coli outbreak
Science Insider via Science Now    Share    Share on FacebookTwitterShare on LinkedinE-mail
article
Just from the high number of deaths and severe cases, scientists and public health experts battling Germany's massive E. coli outbreak knew they were up against something unusual. Now, early results from sequencing projects of the enterohemorrhagic Escherichia coli strain appear to confirm that a never-before-seen hybrid, combining the worst of several bacterial strains, is causing the havoc. More
Related stories:
4 suspected US cases of E.coli linked to Germany (Reuters)
Survivor of Germany's E. coli outbreak tells stories of pain, hospital chaos and confusion (The Washington Post)


Rapid advances in health care informatics raise stakes for clinical pathology laboratories
DarkDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
During this first year of federal incentives for adoption of electronic health records (EHR), large numbers of hospitals and office-based physicians are actively developing an informatics strategy for their organizations. As these providers acquire and deploy EHR systems, clinical laboratories and pathology groups will need to deliver a robust LIS-to-EMR interface that seamlessly handles medical laboratory test orders and lab test results reporting. More

Qualiris by Stago

Qualiris by Stago is a Web-based External Quality Assessment program used to provide enhanced confidence for your hemostasis testing. Qualiris provides peer-group, result comparisons from a global to a local level. Stago's dedicated experts are available 24/7 to help interpret your results. For more information on Quadfsliris visit www.stago-us.com.


New strain of MRSA found in milk
WebMD via Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have discovered a new strain of antibiotic-resistant superbug bacteria in milk. This previously undetectable strain has also caused human infections. The bacterium, a strain of methicillin-resistant Staphylococcus aureus (MRSA), appears to be relatively rare. It turns up in about 1 percent of MRSA cultured from humans in the U.K. More

CDC: More than 1 million Americans now living with HIV
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Although HIV/AIDS continues to be an epidemic with no cure, thanks to powerful medications more HIV-infected Americans are living longer and healthier lives, federal health officials said. By the close of 2008 there were 1,178,350 people in the United States living with HIV, 20 percent of whom don't know they are infected, according to researchers from the U.S. Centers for Disease Control and Prevention (CDC). More
Related story:
AIDS research focuses on vaccine to prevent infection (Chicago Sun-Times)




Studies find new drugs boost skin cancer survival
The Associated Press via Google News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Two novel drugs produced unprecedented gains in survival in separate studies of people with melanoma, the deadliest form of skin cancer. In one study, an experimental drug showed so much benefit so quickly in people with advanced disease that those getting a comparison drug were allowed to switch after just a few months. More

Stem cell treatment to prevent leukemia returning is a step closer
Science Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at King's College London have identified a way of eliminating leukemic stem cells, which could lead to new treatments that may enable complete remission for leukemia patients. An early study in mice has shown that leukemic stem cells can be abolished by suppressing two proteins found in the body. More



Gene tests don't help detect disease of right ventricular myocardium
Reuters via Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Genetic testing should not be used to screen for arrhythmogenic right ventricular cardiomyopathy/dysplasia, according to a new report. "The potential for false positives is currently among the highest of all genetic tests for inherited heart diseases," said Dr. Michael J. Ackerman from Mayo Clinic in Rochester, Minn. More

Cellphones may be carcinogenic
Laboratory Equipment    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A respected international panel of experts says cellphones are possible cancer-causing agents, putting them in the same category as the pesticide DDT, gasoline engine exhaust and coffee. The classification was issued in Lyon, France, by the International Agency for Research on Cancer after a review of dozens of published studies. The agency is an arm of the World Health Organization and its assessment now goes to WHO and national health agencies for possible guidance on cellphone use. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Contact us at 1-800-379-0957.
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes.
More
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Colby Horton, Vice President of Publishing
469.420.2601

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor
469.420.2641.

Recent Issues

  • May 31, 2011
  • Dedicated - Fisher Healthcare - May 2011
  • May 24, 2011
  • May 17, 2011
  • May 10, 2011
  •  RSS Feed
    Most popular articles